Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amn Healthcare Services (AMN) Non-Current Debt (2016 - 2025)

Amn Healthcare Services' Non-Current Debt history spans 16 years, with the latest figure at $742.1 million for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 253.36% year-over-year to $742.1 million; the TTM value through Dec 2025 reached $742.1 million, up 253.36%, while the annual FY2025 figure was $742.1 million, 253.36% up from the prior year.
  • Non-Current Debt reached $742.1 million in Q4 2025 per AMN's latest filing, down from $846.8 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $846.8 million in Q3 2025 to a low of $140.0 million in Q1 2023.
  • Average Non-Current Debt over 5 years is $744.0 million, with a median of $843.1 million recorded in 2022.
  • Peak YoY movement for Non-Current Debt: plummeted 83.39% in 2023, then surged 503.56% in 2024.
  • A 5-year view of Non-Current Debt shows it stood at $842.3 million in 2021, then rose by 0.14% to $843.5 million in 2022, then rose by 0.14% to $844.7 million in 2023, then crashed by 75.14% to $210.0 million in 2024, then skyrocketed by 253.36% to $742.1 million in 2025.
  • Per Business Quant, the three most recent readings for AMN's Non-Current Debt are $742.1 million (Q4 2025), $846.8 million (Q3 2025), and $846.5 million (Q2 2025).